Evidence map›Paper›PMID 40028329›Full record

ReviewFrontiers in immunology2025

The role of oxidative post-translational modifications in type 1 diabetes pathogenesis.

Ghadeer Alhamar, Chiara Vinci, Valentina Franzese, Flavia Tramontana, Nelig Le Goux, Johnny Ludvigsson, Ahuva Nissim, Rocky Strollo

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ghadeer Alhamar *Department of Immunology and Microbiology, Dasman Diabetes Institute, Dasman, Kuwait.
Chiara Vinci *Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
Valentina FranzeseDepartment for the Promotion of Human Science and Quality of Life, San Raffaele Open University, Rome, Italy.
Flavia TramontanaDepartment of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.
Nelig Le GouxBiochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Johnny Ludvigsson *Crown Princess Victoria Children's Hospital and Division of Pediatrics, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Ahuva Nissim *Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Rocky Strollo *Department for the Promotion of Human Science and Quality of Life, San Raffaele Open University, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis of type 1 diabetes (T1D) involves a complex interplay of genetic predisposition, immune processes, and environmental factors, leading to the selective destruction of pancreatic beta-cells by the immune system. Emerging evidence suggests that intrinsic beta-cell factors, including oxidative stress and post-translational modifications (PTM) of beta-cell antigens, may also contribute to their immunogenicity, shedding new light on the multifaceted pathogenesis of T1D. Over the past 30 years, neoepitopes generated by PTMs have been hypothesized to play a role in T1D pathogenesis, but their involvement has only been systematically investigated in recent years. In this review, we explored the interplay between oxidative PTMs, neoepitopes, and T1D, highlighting oxidative stress as a pivotal factor in immune system dysfunction, beta-cell vulnerability, and disease onset.

Indexed as

Diabetes Mellitus, Type 1Insulin-Secreting CellsOxidative StressProtein Processing, Post-TranslationalAnimalsAutoantigensEpitopesHumansOxidation-ReductionAutoantigensEpitopesautoantibodiesautoimmunityinsulinneoepitopesoxidative stresspost-translational modificationst celltype 1 diabetes

Identifiers

PMID40028329
PMCPMC11868110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.